0001104659-16-111174.txt : 20160413 0001104659-16-111174.hdr.sgml : 20160413 20160413110500 ACCESSION NUMBER: 0001104659-16-111174 CONFORMED SUBMISSION TYPE: 497 PUBLIC DOCUMENT COUNT: 16 FILED AS OF DATE: 20160413 DATE AS OF CHANGE: 20160413 EFFECTIVENESS DATE: 20160413 FILER: COMPANY DATA: COMPANY CONFORMED NAME: UBS FUNDS CENTRAL INDEX KEY: 0000886244 IRS NUMBER: 367056204 STATE OF INCORPORATION: DE FISCAL YEAR END: 0630 FILING VALUES: FORM TYPE: 497 SEC ACT: 1933 Act SEC FILE NUMBER: 033-47287 FILM NUMBER: 161568617 BUSINESS ADDRESS: STREET 1: C/O UBS ASSET MANAGEMENT (AMERICAS) INC STREET 2: ONE NORTH WACKER DR. CITY: CHICAGO STATE: IL ZIP: 60606 BUSINESS PHONE: 312-525-7100 MAIL ADDRESS: STREET 1: C/O UBS ASSET MANAGEMENT (AMERICAS) INC STREET 2: ONE NORTH WACKER DR. CITY: CHICAGO STATE: IL ZIP: 60606 FORMER COMPANY: FORMER CONFORMED NAME: BRINSON FUNDS INC DATE OF NAME CHANGE: 19920929 0000886244 S000002978 UBS U.S. Large Cap Equity Fund C000008178 Class A BNEQX C000008180 CLASS C BNQCX C000008181 CLASS P BPEQX 497 1 a16-7027_12497.htm 497

 

GRAPHIC

Stradley Ronon Stevens & Young, LLP

Suite 2600

2005 Market Street

Philadelphia, PA 19103-7018

Telephone 215.564.8000

Fax 215.564.8120

www.stradley.com

 

Direct Dial - (215) 564-8543

 

1933 Act Rule 497(e)

1933 Act File No. 033-47287

1940 Act File No. 811-06637

 

April 13, 2016

 

VIA EDGAR

 

Filing Desk

U.S. Securities and Exchange Commission

100 F Street, N.E.

Washington, D.C.  20549-0505

 

Re:

XBRL Exhibits

 

The UBS Funds (“Registrant”)

 

File Nos. 033-47287 and 811-06637

 

Dear Sir or Madam:

 

Pursuant to Rule 497(e) under the Securities Act of 1933, as amended, (the “1933 Act”) submitted electronically via the EDGAR system, please find enclosed certain risk/return summary information in an interactive data format using the eXtensible Business Reporting Language (the “XBRL exhibits”).  The XBRL exhibits reflect the risk/return summary disclosure that was included in the supplement to the prospectus dated October 28, 2015, as supplemented, relating to the UBS U.S. Large Cap Equity Fund, a series of the Registrant, that was filed with the U.S. Securities and Exchange Commission via the EDGAR system on March 23, 2016 (Accession No. 0001609006-16-000377) pursuant to Rule 497(e) under the 1933 Act.

 

Please direct questions or comments relating to this filing to me at the above telephone number.

 

 

Very truly yours,

 

 

 

 

 

/s/ Jamie M. Gershkow

 

Jamie M. Gershkow

 


EX-101.INS 2 ck0000886244-20160323.xml XBRL INSTANCE DOCUMENT 0000886244 2016-03-23 2016-03-23 0000886244 ck0000886244:S000002978Member 2016-03-23 2016-03-23 0000886244 ck0000886244:S000002978Member ck0000886244:C000008178Member 2016-03-23 2016-03-23 0000886244 ck0000886244:S000002978Member ck0000886244:C000008180Member 2016-03-23 2016-03-23 0000886244 ck0000886244:S000002978Member ck0000886244:C000008181Member 2016-03-23 2016-03-23 xbrli:pure iso4217:USD Purchases of $1 million or more that were not subject to a front-end sales charge are subject to a 1% CDSC if sold within one year of the purchase date. "Other expenses" include "Acquired fund fees and expenses," which were less than 0.01% of the average net assets of the Fund. The "Less management fee waiver/expense reimbursements" and "Total annual fund operating expenses after management fee waiver/expense reimbursements" are restated to reflect a change in the Fund's expense limitation agreement. Effective March 23, 2016, the Trust, with respect to the Fund, and UBS Asset Management (Americas) Inc. (formerly, UBS Global Asset Management (Americas) Inc.), the Fund's investment advisor ("UBS AM (Americas)" or the "Advisor"), have entered into a written agreement pursuant to which the Advisor has agreed to waive a portion of its management fees and/or to reimburse expenses (excluding expenses incurred through investment in other investment companies, interest, taxes, brokerage commissions and extraordinary expenses) to the extent necessary so that the Fund's ordinary operating expenses (excluding expenses incurred through investment in other investment companies, interest, taxes, brokerage commissions and extraordinary expenses), through the period ending October 27, 2017, do not exceed 0.95% for Class A shares, 1.70% for Class C shares and 0.70% for Class P shares. Pursuant to the written agreement, the Advisor is entitled to be reimbursed for any fees it waives and expenses it reimburses for a period of three years following such fee waivers and expense reimbursements to the extent that such reimbursement of the Advisor by the Fund will not cause the Fund to exceed any applicable expense limit that is in place for the Fund. The fee waiver/expense reimbursement agreement may be terminated by the Fund's Board of Trustees at any time and also will terminate automatically upon the expiration or termination of the Fund's advisory contract with the Advisor. Upon termination of the fee waiver/expense reimbursement agreement, however, the UBS AM (Americas)'s three year recoupment rights will survive. UBS FUNDS 497 false 0000886244 2016-03-23 2016-03-23 2016-03-23 2015-10-28 UBS U.S. Large Cap Equity Fund BNEQX BNQCX BPEQX <table cellpadding="0" cellspacing="0" style="font-size: 10pt; font-family: times new roman; width: 100%;"> <tr> <td align="left" valign="top" width="34%"> <div align="left" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"> </div></td> <td align="left" style="border-left: black 2px solid;" valign="bottom" width="28%"> <div align="left" style="text-indent: 0pt; display: block; margin-left: 9pt; margin-right: 0pt;"> <font style="display: inline; font-family: times new roman; font-size: 10pt;">The UBS Funds</font> </div></td> <td align="left" style="border-left: black 2px solid;" valign="bottom" width="20%"> <div align="left" style="text-indent: 0pt; display: block; margin-left: 9pt; margin-right: 0pt;"> <font style="display: inline; font-family: times new roman; font-size: 10pt;">Prospectus Supplement</font> </div></td> </tr> </table> <br/><div align="justify" style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"> <font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 24pt">The UBS Funds</font> </div> <br/><div align="justify" style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"> <font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 24pt; FONT-WEIGHT: bold">UBS U.S. Large Cap Equity Fund</font> </div> <br/><div align="left" style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"> <font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">Prospectus Supplement</font> </div> <br/><div align="left" style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"> <font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">March 23, 2016</font> </div> <br/><div align="left" style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"> <font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Dear Investor,</font> </div> <br/><div align="justify" style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"> <font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">The purpose of this supplement to the Prospectus of the UBS U.S. Large Cap Equity Fund series (the "Fund") of The UBS Funds (the "Trust") dated October 28, 2015, as supplemented, is to notify you that on March 3, 2016, the Board of Trustees of the Trust approved a new expense limitation agreement for the Fund.&#160;&#160;The new expense limitation agreement decreases the expense caps by 25 basis points for each class of the Fund and extends the period of the agreement from October 27, 2016 to October 27, 2017.</font> </div> <br/><div align="justify" style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"> <font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Therefore, on pages 7-8 of the Prospectus, the Fund&#8217;s Shareholder fees, Annual fund operating expenses, and Example tables are deleted in their entirety and replaced with the following:</font> </div> 0.0550 0.0000 0.0000 0.0000 0.0100 0.0000 0.0070 0.0070 0.0070 0.0025 0.0100 0.0000 0.0061 0.0061 0.0037 0.0156 0.0231 0.0107 -0.0061 -0.0061 -0.0037 0.0095 0.0170 0.0070 ~ http://ubs.com/20160323/role/ScheduleShareholderFees20001 column dei_LegalEntityAxis compact ck0000886244_S000002978Member row primary compact * ~ ~ http://ubs.com/20160323/role/ScheduleAnnualFundOperatingExpenses20002 column dei_LegalEntityAxis compact ck0000886244_S000002978Member row primary compact * ~ The &#8220;Less management fee waiver/expense reimbursements&#8221; and &#8220;Total annual fund operating expenses after management fee waiver/expense reimbursements&#8221; are restated to reflect a change in the Fund&#8217;s expense limitation agreement. 2017-10-27 Shareholder fees (fees paid directly from your investment) Purchases of $1 million or more that were not subject to a front-end sales charge are subject to a 1% CDSC if sold within one year of the purchase date. Annual fund operating expenses (expenses that you pay each year as a percentage of the value of your investment) Example <div align="justify" style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"> <font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">This example is intended to help you compare the cost of investing in the Fund with the cost of investing in other mutual funds. The example assumes that you invest $10,000 in the Fund for the time periods indicated and then sell all of your shares at the end of those periods unless otherwise stated. The example also assumes that your investment has a 5% return each year and that the Fund's operating expenses remain the same. The costs described in the example reflect the expenses of the Fund that would result from the contractual fee waiver and expense reimbursement agreement with the Advisor for the first year only. Although your actual costs may be higher or lower, based on these assumptions, your costs would be:</font> </div> 642 959 1298 2255 273 663 1180 2599 173 663 1180 2599 72 304 556 1276 ~ http://ubs.com/20160323/role/ScheduleExpenseExampleTransposed20003 column dei_LegalEntityAxis compact ck0000886244_S000002978Member row primary compact * ~ ~ http://ubs.com/20160323/role/ScheduleExpenseExampleNoRedemptionTransposed20004 column dei_LegalEntityAxis compact ck0000886244_S000002978Member row primary compact * ~ <div align="justify" style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"> <font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">PLEASE BE SURE TO RETAIN THIS IMPORTANT INFORMATION FOR FUTURE REFERENCE.</font> </div> EX-101.SCH 3 ck0000886244-20160323.xsd XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT 000001 - Document - Document and Entity Information link:presentationLink link:definitionLink link:calculationLink 020000 - Document - Risk/Return Summary {Unlabeled} - UBS U.S. Large Cap Equity Fund link:presentationLink link:definitionLink link:calculationLink 020001 - Schedule - Shareholder Fees link:presentationLink link:definitionLink link:calculationLink 020002 - Schedule - Annual Fund Operating Expenses link:presentationLink link:definitionLink link:calculationLink 020003 - Schedule - Expense Example {Transposed} link:presentationLink link:definitionLink link:calculationLink 020004 - Schedule - Expense Example No Redemption {Transposed} link:presentationLink link:definitionLink link:calculationLink 020005 - Disclosure - Risk/Return Detail Data {Elements} - UBS U.S. Large Cap Equity Fund link:presentationLink link:definitionLink link:calculationLink EX-101.LAB 4 ck0000886244-20160323_lab.xml XBRL TAXONOMY EXTENSION LABELS LINKBASE DOCUMENT EX-101.DEF 5 ck0000886244-20160323_def.xml XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT EX-101.PRE 6 ck0000886244-20160323_pre.xml XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT EX-101.CAL 7 ck0000886244-20160323_cal.xml XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT GRAPHIC 8 g702712cai001.jpg GRAPHIC begin 644 g702712cai001.jpg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end XML 9 R1.htm IDEA: XBRL DOCUMENT v3.3.1.900
Document and Entity Information
Total
Prospectus:  
Document Type 497
Document Period End Date Mar. 23, 2016
Registrant Name UBS FUNDS
Central Index Key 0000886244
Amendment Flag false
Document Creation Date Mar. 23, 2016
Document Effective Date Mar. 23, 2016
Prospectus Date Oct. 28, 2015
UBS U.S. Large Cap Equity Fund | Class A  
Prospectus:  
Trading Symbol BNEQX
UBS U.S. Large Cap Equity Fund | CLASS C  
Prospectus:  
Trading Symbol BNQCX
UBS U.S. Large Cap Equity Fund | CLASS P  
Prospectus:  
Trading Symbol BPEQX
XML 10 R2.htm IDEA: XBRL DOCUMENT v3.3.1.900
UBS U.S. Large Cap Equity Fund
UBS U.S. Large Cap Equity Fund
The UBS Funds
Prospectus Supplement

The UBS Funds

UBS U.S. Large Cap Equity Fund

Prospectus Supplement

March 23, 2016

Dear Investor,

The purpose of this supplement to the Prospectus of the UBS U.S. Large Cap Equity Fund series (the "Fund") of The UBS Funds (the "Trust") dated October 28, 2015, as supplemented, is to notify you that on March 3, 2016, the Board of Trustees of the Trust approved a new expense limitation agreement for the Fund.  The new expense limitation agreement decreases the expense caps by 25 basis points for each class of the Fund and extends the period of the agreement from October 27, 2016 to October 27, 2017.

Therefore, on pages 7-8 of the Prospectus, the Fund’s Shareholder fees, Annual fund operating expenses, and Example tables are deleted in their entirety and replaced with the following:
Shareholder fees (fees paid directly from your investment)
Shareholder Fees - UBS U.S. Large Cap Equity Fund
Class A
CLASS C
CLASS P
Maximum front-end sales charge (load) imposed on purchases (as a % of offering price) 5.50% none none
Maximum contingent deferred sales charge (load) (CDSC) (as a % of purchase or sales price, whichever is less) none [1] 1.00% none
[1] Purchases of $1 million or more that were not subject to a front-end sales charge are subject to a 1% CDSC if sold within one year of the purchase date.
Annual fund operating expenses (expenses that you pay each year as a percentage of the value of your investment)
Annual Fund Operating Expenses - UBS U.S. Large Cap Equity Fund
Class A
CLASS C
CLASS P
Management fees 0.70% 0.70% 0.70%
Distribution and/or service (12b-1) fees 0.25% 1.00% none
Other expenses [1] 0.61% 0.61% 0.37%
Total annual fund operating expenses 1.56% 2.31% 1.07%
Less management fee waiver/expense reimbursements [2] 0.61% 0.61% 0.37%
Total annual fund operating expenses after management fee waiver/expense reimbursements [2],[3] 0.95% 1.70% 0.70%
[1] "Other expenses" include "Acquired fund fees and expenses," which were less than 0.01% of the average net assets of the Fund.
[2] The "Less management fee waiver/expense reimbursements" and "Total annual fund operating expenses after management fee waiver/expense reimbursements" are restated to reflect a change in the Fund's expense limitation agreement.
[3] Effective March 23, 2016, the Trust, with respect to the Fund, and UBS Asset Management (Americas) Inc. (formerly, UBS Global Asset Management (Americas) Inc.), the Fund's investment advisor ("UBS AM (Americas)" or the "Advisor"), have entered into a written agreement pursuant to which the Advisor has agreed to waive a portion of its management fees and/or to reimburse expenses (excluding expenses incurred through investment in other investment companies, interest, taxes, brokerage commissions and extraordinary expenses) to the extent necessary so that the Fund's ordinary operating expenses (excluding expenses incurred through investment in other investment companies, interest, taxes, brokerage commissions and extraordinary expenses), through the period ending October 27, 2017, do not exceed 0.95% for Class A shares, 1.70% for Class C shares and 0.70% for Class P shares. Pursuant to the written agreement, the Advisor is entitled to be reimbursed for any fees it waives and expenses it reimburses for a period of three years following such fee waivers and expense reimbursements to the extent that such reimbursement of the Advisor by the Fund will not cause the Fund to exceed any applicable expense limit that is in place for the Fund. The fee waiver/expense reimbursement agreement may be terminated by the Fund's Board of Trustees at any time and also will terminate automatically upon the expiration or termination of the Fund's advisory contract with the Advisor. Upon termination of the fee waiver/expense reimbursement agreement, however, the UBS AM (Americas)'s three year recoupment rights will survive.
Example
This example is intended to help you compare the cost of investing in the Fund with the cost of investing in other mutual funds. The example assumes that you invest $10,000 in the Fund for the time periods indicated and then sell all of your shares at the end of those periods unless otherwise stated. The example also assumes that your investment has a 5% return each year and that the Fund's operating expenses remain the same. The costs described in the example reflect the expenses of the Fund that would result from the contractual fee waiver and expense reimbursement agreement with the Advisor for the first year only. Although your actual costs may be higher or lower, based on these assumptions, your costs would be:
Expense Example - UBS U.S. Large Cap Equity Fund - USD ($)
1 year
3 years
5 years
10 years
Class A 642 959 1,298 2,255
CLASS C 273 663 1,180 2,599
CLASS P 72 304 556 1,276
Expense Example No Redemption
1 year
3 years
5 years
10 years
UBS U.S. Large Cap Equity Fund | CLASS C | USD ($) 173 663 1,180 2,599
PLEASE BE SURE TO RETAIN THIS IMPORTANT INFORMATION FOR FUTURE REFERENCE.
XML 11 R7.htm IDEA: XBRL DOCUMENT v3.3.1.900
Label Element Value
UBS U.S. Large Cap Equity Fund  
Risk/Return: rr_RiskReturnAbstract  
Supplement [Text Block] ck0000886244_SupplementTextBlock
The UBS Funds
Prospectus Supplement

The UBS Funds

UBS U.S. Large Cap Equity Fund

Prospectus Supplement

March 23, 2016

Dear Investor,

The purpose of this supplement to the Prospectus of the UBS U.S. Large Cap Equity Fund series (the "Fund") of The UBS Funds (the "Trust") dated October 28, 2015, as supplemented, is to notify you that on March 3, 2016, the Board of Trustees of the Trust approved a new expense limitation agreement for the Fund.  The new expense limitation agreement decreases the expense caps by 25 basis points for each class of the Fund and extends the period of the agreement from October 27, 2016 to October 27, 2017.

Therefore, on pages 7-8 of the Prospectus, the Fund’s Shareholder fees, Annual fund operating expenses, and Example tables are deleted in their entirety and replaced with the following:
Risk/Return [Heading] rr_RiskReturnHeading UBS U.S. Large Cap Equity Fund
Shareholder Fees Caption [Text] rr_ShareholderFeesCaption Shareholder fees (fees paid directly from your investment)
Operating Expenses Caption [Text] rr_OperatingExpensesCaption Annual fund operating expenses (expenses that you pay each year as a percentage of the value of your investment)
Fee Waiver or Reimbursement over Assets, Date of Termination rr_FeeWaiverOrReimbursementOverAssetsDateOfTermination Oct. 27, 2017
Expenses Restated to Reflect Current [Text] rr_ExpensesRestatedToReflectCurrent The “Less management fee waiver/expense reimbursements” and “Total annual fund operating expenses after management fee waiver/expense reimbursements” are restated to reflect a change in the Fund’s expense limitation agreement.
Expense Example [Heading] rr_ExpenseExampleHeading Example
Expense Example Narrative [Text Block] rr_ExpenseExampleNarrativeTextBlock
This example is intended to help you compare the cost of investing in the Fund with the cost of investing in other mutual funds. The example assumes that you invest $10,000 in the Fund for the time periods indicated and then sell all of your shares at the end of those periods unless otherwise stated. The example also assumes that your investment has a 5% return each year and that the Fund's operating expenses remain the same. The costs described in the example reflect the expenses of the Fund that would result from the contractual fee waiver and expense reimbursement agreement with the Advisor for the first year only. Although your actual costs may be higher or lower, based on these assumptions, your costs would be:
Expense Example Closing [Text Block] rr_ExpenseExampleClosingTextBlock
PLEASE BE SURE TO RETAIN THIS IMPORTANT INFORMATION FOR FUTURE REFERENCE.
UBS U.S. Large Cap Equity Fund | Class A  
Risk/Return: rr_RiskReturnAbstract  
Maximum front-end sales charge (load) imposed on purchases (as a % of offering price) rr_MaximumSalesChargeImposedOnPurchasesOverOfferingPrice 5.50%
Maximum contingent deferred sales charge (load) (CDSC) (as a % of purchase or sales price, whichever is less) rr_MaximumDeferredSalesChargeOverOther none [1]
Management fees rr_ManagementFeesOverAssets 0.70%
Distribution and/or service (12b-1) fees rr_DistributionAndService12b1FeesOverAssets 0.25%
Other expenses rr_OtherExpensesOverAssets 0.61% [2]
Total annual fund operating expenses rr_ExpensesOverAssets 1.56%
Fee Waiver or Reimbursement rr_FeeWaiverOrReimbursementOverAssets (0.61%) [3]
Total annual fund operating expenses after management fee waiver/expense reimbursements rr_NetExpensesOverAssets 0.95% [3],[4]
Expenses Deferred Charges [Text Block] rr_ExpensesDeferredChargesTextBlock Purchases of $1 million or more that were not subject to a front-end sales charge are subject to a 1% CDSC if sold within one year of the purchase date.
Expense Example, with Redemption, 1 Year rr_ExpenseExampleYear01 $ 642
Expense Example, with Redemption, 3 Years rr_ExpenseExampleYear03 959
Expense Example, with Redemption, 5 Years rr_ExpenseExampleYear05 1,298
Expense Example, with Redemption, 10 Years rr_ExpenseExampleYear10 $ 2,255
UBS U.S. Large Cap Equity Fund | CLASS C  
Risk/Return: rr_RiskReturnAbstract  
Maximum front-end sales charge (load) imposed on purchases (as a % of offering price) rr_MaximumSalesChargeImposedOnPurchasesOverOfferingPrice none
Maximum contingent deferred sales charge (load) (CDSC) (as a % of purchase or sales price, whichever is less) rr_MaximumDeferredSalesChargeOverOther 1.00%
Management fees rr_ManagementFeesOverAssets 0.70%
Distribution and/or service (12b-1) fees rr_DistributionAndService12b1FeesOverAssets 1.00%
Other expenses rr_OtherExpensesOverAssets 0.61% [2]
Total annual fund operating expenses rr_ExpensesOverAssets 2.31%
Fee Waiver or Reimbursement rr_FeeWaiverOrReimbursementOverAssets (0.61%) [3]
Total annual fund operating expenses after management fee waiver/expense reimbursements rr_NetExpensesOverAssets 1.70% [3],[4]
Expense Example, with Redemption, 1 Year rr_ExpenseExampleYear01 $ 273
Expense Example, with Redemption, 3 Years rr_ExpenseExampleYear03 663
Expense Example, with Redemption, 5 Years rr_ExpenseExampleYear05 1,180
Expense Example, with Redemption, 10 Years rr_ExpenseExampleYear10 2,599
Expense Example, No Redemption, 1 Year rr_ExpenseExampleNoRedemptionYear01 173
Expense Example, No Redemption, 3 Years rr_ExpenseExampleNoRedemptionYear03 663
Expense Example, No Redemption, 5 Years rr_ExpenseExampleNoRedemptionYear05 1,180
Expense Example, No Redemption, 10 Years rr_ExpenseExampleNoRedemptionYear10 $ 2,599
UBS U.S. Large Cap Equity Fund | CLASS P  
Risk/Return: rr_RiskReturnAbstract  
Maximum front-end sales charge (load) imposed on purchases (as a % of offering price) rr_MaximumSalesChargeImposedOnPurchasesOverOfferingPrice none
Maximum contingent deferred sales charge (load) (CDSC) (as a % of purchase or sales price, whichever is less) rr_MaximumDeferredSalesChargeOverOther none
Management fees rr_ManagementFeesOverAssets 0.70%
Distribution and/or service (12b-1) fees rr_DistributionAndService12b1FeesOverAssets none
Other expenses rr_OtherExpensesOverAssets 0.37% [2]
Total annual fund operating expenses rr_ExpensesOverAssets 1.07%
Fee Waiver or Reimbursement rr_FeeWaiverOrReimbursementOverAssets (0.37%) [3]
Total annual fund operating expenses after management fee waiver/expense reimbursements rr_NetExpensesOverAssets 0.70% [3],[4]
Expense Example, with Redemption, 1 Year rr_ExpenseExampleYear01 $ 72
Expense Example, with Redemption, 3 Years rr_ExpenseExampleYear03 304
Expense Example, with Redemption, 5 Years rr_ExpenseExampleYear05 556
Expense Example, with Redemption, 10 Years rr_ExpenseExampleYear10 $ 1,276
[1] Purchases of $1 million or more that were not subject to a front-end sales charge are subject to a 1% CDSC if sold within one year of the purchase date.
[2] "Other expenses" include "Acquired fund fees and expenses," which were less than 0.01% of the average net assets of the Fund.
[3] The "Less management fee waiver/expense reimbursements" and "Total annual fund operating expenses after management fee waiver/expense reimbursements" are restated to reflect a change in the Fund's expense limitation agreement.
[4] Effective March 23, 2016, the Trust, with respect to the Fund, and UBS Asset Management (Americas) Inc. (formerly, UBS Global Asset Management (Americas) Inc.), the Fund's investment advisor ("UBS AM (Americas)" or the "Advisor"), have entered into a written agreement pursuant to which the Advisor has agreed to waive a portion of its management fees and/or to reimburse expenses (excluding expenses incurred through investment in other investment companies, interest, taxes, brokerage commissions and extraordinary expenses) to the extent necessary so that the Fund's ordinary operating expenses (excluding expenses incurred through investment in other investment companies, interest, taxes, brokerage commissions and extraordinary expenses), through the period ending October 27, 2017, do not exceed 0.95% for Class A shares, 1.70% for Class C shares and 0.70% for Class P shares. Pursuant to the written agreement, the Advisor is entitled to be reimbursed for any fees it waives and expenses it reimburses for a period of three years following such fee waivers and expense reimbursements to the extent that such reimbursement of the Advisor by the Fund will not cause the Fund to exceed any applicable expense limit that is in place for the Fund. The fee waiver/expense reimbursement agreement may be terminated by the Fund's Board of Trustees at any time and also will terminate automatically upon the expiration or termination of the Fund's advisory contract with the Advisor. Upon termination of the fee waiver/expense reimbursement agreement, however, the UBS AM (Americas)'s three year recoupment rights will survive.
XML 12 R8.htm IDEA: XBRL DOCUMENT v3.3.1.900
Label Element Value
Risk/Return: rr_RiskReturnAbstract  
Prospectus Date rr_ProspectusDate Oct. 28, 2015
XML 13 Show.js IDEA: XBRL DOCUMENT /** * Rivet Software Inc. * * @copyright Copyright (c) 2006-2011 Rivet Software, Inc. All rights reserved. * Version 2.4.0.3 * */ var Show = {}; Show.LastAR = null, Show.hideAR = function(){ Show.LastAR.style.display = 'none'; }; Show.showAR = function ( link, id, win ){ if( Show.LastAR ){ Show.hideAR(); } var ref = link; do { ref = ref.nextSibling; } while (ref && ref.nodeName != 'TABLE'); if (!ref || ref.nodeName != 'TABLE') { var tmp = win ? win.document.getElementById(id) : document.getElementById(id); if( tmp ){ ref = tmp.cloneNode(true); ref.id = ''; link.parentNode.appendChild(ref); } } if( ref ){ ref.style.display = 'block'; Show.LastAR = ref; } }; Show.toggleNext = function( link ){ var ref = link; do{ ref = ref.nextSibling; }while( ref.nodeName != 'DIV' ); if( ref.style && ref.style.display && ref.style.display == 'none' ){ ref.style.display = 'block'; if( link.textContent ){ link.textContent = link.textContent.replace( '+', '-' ); }else{ link.innerText = link.innerText.replace( '+', '-' ); } }else{ ref.style.display = 'none'; if( link.textContent ){ link.textContent = link.textContent.replace( '-', '+' ); }else{ link.innerText = link.innerText.replace( '-', '+' ); } } }; XML 14 report.css IDEA: XBRL DOCUMENT /* Updated 2009-11-04 */ /* v2.2.0.24 */ /* DefRef Styles */ ..report table.authRefData{ background-color: #def; border: 2px solid #2F4497; font-size: 1em; position: absolute; } ..report table.authRefData a { display: block; font-weight: bold; } ..report table.authRefData p { margin-top: 0px; } ..report table.authRefData .hide { background-color: #2F4497; padding: 1px 3px 0px 0px; text-align: right; } ..report table.authRefData .hide a:hover { background-color: #2F4497; } ..report table.authRefData .body { height: 150px; overflow: auto; width: 400px; } ..report table.authRefData table{ font-size: 1em; } /* Report Styles */ ..pl a, .pl a:visited { color: black; text-decoration: none; } /* table */ ..report { background-color: white; border: 2px solid #acf; clear: both; color: black; font: normal 8pt Helvetica, Arial, san-serif; margin-bottom: 2em; } ..report hr { border: 1px solid #acf; } /* Top labels */ ..report th { background-color: #acf; color: black; font-weight: bold; text-align: center; } ..report th.void { background-color: transparent; color: #000000; font: bold 10pt Helvetica, Arial, san-serif; text-align: left; } ..report .pl { text-align: left; vertical-align: top; white-space: normal; width: 200px; white-space: normal; /* word-wrap: break-word; */ } ..report td.pl a.a { cursor: pointer; display: block; width: 200px; overflow: hidden; } ..report td.pl div.a { width: 200px; } ..report td.pl a:hover { background-color: #ffc; } /* Header rows... */ ..report tr.rh { background-color: #acf; color: black; font-weight: bold; } /* Calendars... */ ..report .rc { background-color: #f0f0f0; } /* Even rows... */ ..report .re, .report .reu { background-color: #def; } ..report .reu td { border-bottom: 1px solid black; } /* Odd rows... */ ..report .ro, .report .rou { background-color: white; } ..report .rou td { border-bottom: 1px solid black; } ..report .rou table td, .report .reu table td { border-bottom: 0px solid black; } /* styles for footnote marker */ ..report .fn { white-space: nowrap; } /* styles for numeric types */ ..report .num, .report .nump { text-align: right; white-space: nowrap; } ..report .nump { padding-left: 2em; } ..report .nump { padding: 0px 0.4em 0px 2em; } /* styles for text types */ ..report .text { text-align: left; white-space: normal; } ..report .text .big { margin-bottom: 1em; width: 17em; } ..report .text .more { display: none; } ..report .text .note { font-style: italic; font-weight: bold; } ..report .text .small { width: 10em; } ..report sup { font-style: italic; } ..report .outerFootnotes { font-size: 1em; } XML 16 FilingSummary.xml IDEA: XBRL DOCUMENT 3.3.1.900 html 5 39 1 true 4 0 false 2 false false R1.htm 000001 - Document - Document and Entity Information Sheet http://ubs.com/20160323/role/DocumentAndEntityInformation Document and Entity Information 1 false true R2.htm 020000 - Document - Risk/Return Summary {Unlabeled} - UBS U.S. Large Cap Equity Fund Sheet http://ubs.com/20160323/role/DocumentRiskReturnSummaryUnlabeledUBSUSLargeCapEquityFund Risk/Return Summary- UBS U.S. Large Cap Equity Fund 2 false false R7.htm 020005 - Disclosure - Risk/Return Detail Data {Elements} - UBS U.S. Large Cap Equity Fund Sheet http://ubs.com/20160323/role/DisclosureRiskReturnDetailDataElementsUBSUSLargeCapEquityFund Risk/Return Detail Data- UBS U.S. Large Cap Equity Fund 3 false false R8.htm 040000 - Disclosure - Risk/Return Detail Data {Elements} Sheet http://xbrl.sec.gov/rr/role/RiskReturnDetailData Risk/Return Detail Data 4 false false All Reports Book All Reports ck0000886244-20160323.xml ck0000886244-20160323.xsd ck0000886244-20160323_cal.xml ck0000886244-20160323_def.xml ck0000886244-20160323_lab.xml ck0000886244-20160323_pre.xml true true ZIP 18 0001104659-16-111174-xbrl.zip IDEA: XBRL DOCUMENT begin 644 0001104659-16-111174-xbrl.zip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